Timing of Tourniquet Release, A Prospective Randomized Trial
- Conditions
- Injury
- Interventions
- Procedure: Upper extremity orthopedic surgeries.
- Registration Number
- NCT06576869
- Lead Sponsor
- Orlando Health, Inc.
- Brief Summary
This will be a prospective randomized clinical trial comparing clinical outcome measures in patients who undergo elective upper extremity surgery when tourniquet is dropped prior to closure as opposed to when tourniquet is dropped after closure. The study will compare objective data obtained intraoperatively as well as standard clinical outcome measures such as pain scores at routine follow up.
- Detailed Description
Patients will be enrolled prior to surgery and consented to participate in the study \[HPJ2\]. Patients will be enrolled by the research staff with a provider including attending and resident surgeons as well as advanced practiced providers that are assigned to the upper extremity team. A computerized random number generator will be used to randomize patient allocation to either study arm: closure without releasing the tourniquet vs releasing the tourniquet and then closing the incision. Randomization will occur at the time of surgery. In order to standardize the procedure a 4-inch ace wrap will be wrapped around the upper arm and a tourniquet will be placed over this in order to ensure adequate padding \[HPJ3\] \[AW4\]. At the conclusion of the surgical procedure but prior to skin closure, the randomized number will be revealed to the surgeon and the surgeon will either release the tourniquet or will keep the tourniquet inflated and then close the skin.
After the surgery is completed, information will be collected on the intraoperative data collection form to include:
* Length and exact location of incision
* Whether the patient is on anticoagulant medication.,
* This includes type/dose of medication
* Duration for taking the medication
* Was the medication halted prior to surgery; if so, when
* Surgeon performing the surgery
* Surgical procedure
* Surgery location (ACC, ORMC, etc.)
* When tourniquet is dropped (before/after closure)
* Tourniquet Time
* Time from tourniquet release to closure
* Total Surgical time (time from incision until complete skin closure)
* Turnover time
* Was electrocautery required to control any bleeding; if so, what type and what was electrocauterized?
Clinical outcome measures collected during postoperative follow up.
* Visual analog pain scale
* Quick DASH form
* Complications including hematoma size
* Satisfaction with treatment (scale 1-5)
o completely satisfied - 5, somewhat satisfied - 4, neither satisfied or dissatisfied - 3, partly dissatisfied - 2, completely dissatisfied - 1
* Likely to recommend this surgery to a friend family member who has the same condition - yes or no
Patients enrolled in the study will follow up in clinic at the following time intervals: 2 weeks, 10 weeks, and 6 months per standard of care.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 214
- Consented study subjects 18 years or older
- Subjects with any upper extremity injury or ailment that would require the use of a tourniquet while doing surgery
- Subject undergoing surgery by one of the six fellowship trained Orlando Health upper extremity surgeons previous listed
- Subject without prior surgery to the operative extremity
- Subject under the age of 18 at the time of consent/enrollment
- Subject has had previous surgical procedures at the surgery site
- Subject with bleeding disorder comorbidities
- Subjects who have tourniquet released and then re-inflated during their procedure
- Subjects who do not have English as their preferred language and require an interpreter.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description A: Closure without releasing the tourniquet. Upper extremity orthopedic surgeries. Tourniquet is dropped after closure. B: Releasing the tourniquet and then closing the incision Upper extremity orthopedic surgeries. Tourniquet is dropped prior to closure.
- Primary Outcome Measures
Name Time Method Hematoma assessment 2 weeks, 10 weeks, 6 months. Performed by MD, assessment of the presence of a hematoma and if present, it is measured.
Quick DASH form 2 weeks, 10 weeks, 6 months. Assessment of symptoms and ability to perform certain activities.
Visual analog pain scale 2 weeks, 10 weeks and 6 months. Visual number scale to rate pain.
Satisfaction with surgery 2 weeks, 10 weeks, 6 months. Patient to rate their satisfaction with their surgery and to indicate whether or not they would recommend the surgery to family/friends with the same condition.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Orlando Health Jewett Orthopedic Institute
🇺🇸Orlando, Florida, United States